ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases.ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 12, 2007 | Series B | $18M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Peierls Foundation | — | Series B |